Project Grant HT94252510451
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
This federal Project Grant award in the amount of $197,400.00, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of patient-derived central nervous system (CNS) metastasis models with STK11 inactivation for drug discovery. The award was granted to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a prominent academic research institution. The project...
This federal Project Grant award, provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), is supporting research at The Trustees of Columbia University in the City of New York to advance the potential of the WRN gene as a therapeutic target for microsatellite instability-high (MSI-H) cancers. The $1,316,000 award, effective from August 1, 2025 through July 31, 2029, will fund sophisticated biomedical research initiatives...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
The Department of the Army Medical Command has awarded a $879,721 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Trustees of Columbia University in the City of New York. The grant, which runs from April 1, 2025 to March 31, 2027, will support the "Evaluation of Small Molecule Ferroptosis Inhibitors in a GPX4 ALS Model". This research aims to explore innovative approaches to disease prevention, diagnosis, treatment, and...
The Trustees of Columbia University in the City of New York received a three-year, $729,000 Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this award, Columbia University will conduct research from March 2021 to February 2024 to decipher the mechanisms that drive breast...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
The Defense Health Agency awarded a $1,695,794 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to develop a state-of-the-art microbur-driven non-absorbable epithelial SERT antagonist to treat anxiety and depression in military members and the general public. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports basic, applied, and advanced biomedical research to...
This $159,900 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports preclinical research on brain metastases in lung cancer. The award will fund studies at the University of Illinois to develop and evaluate novel drug efficacy and resistance models for advancing the treatment of brain metastases, a significant challenge in lung cancer management. Spanning one year from August 2024 to August...
The federal Project Grant award of $1,644,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating the role of Streptococcus in esophageal neoplasia. The primary awardee, The Trustees of Columbia University in the City of New York, will leverage its expertise in biomedical research, public health, and medicine to conduct this 3-year research project from...
This $1,645,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports advanced biomedical research at The Trustees of Columbia University in the City of New York, focused on "BONE FRACTURE-INDUCED JOINT BLEEDING AND POSTTRAUMATIC OSTEOARTHRITIS". The award period runs from May 1, 2025 through April 30, 2028, and aims to transform healthcare for military service members and the general...